HomeCompareHRVIX vs ORCC

HRVIX vs ORCC: Dividend Comparison 2026

HRVIX yields 0.59% · ORCC yields 9.79%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ORCC wins by $903.00 in total portfolio value
10 years
HRVIX
HRVIX
● Live price
0.59%
Share price
$37.77
Annual div
$0.22
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.5K
Annual income
$61.47
Full HRVIX calculator →
ORCC
ORCC
● Live price
9.79%
Share price
$13.48
Annual div
$1.32
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.4K
Annual income
$1.04
Full ORCC calculator →

Portfolio growth — HRVIX vs ORCC

📍 ORCC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHRVIXORCC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HRVIX + ORCC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HRVIX pays
ORCC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HRVIX
Annual income on $10K today (after 15% tax)
$50.28/yr
After 10yr DRIP, annual income (after tax)
$52.25/yr
ORCC
Annual income on $10K today (after 15% tax)
$832.34/yr
After 10yr DRIP, annual income (after tax)
$0.88/yr
At 15% tax rate, HRVIX beats the other by $51.37/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HRVIX + ORCC for your $10,000?

HRVIX: 50%ORCC: 50%
100% ORCC50/50100% HRVIX
Portfolio after 10yr
$21.0K
Annual income
$31.26/yr
Blended yield
0.15%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ORCC right now

HRVIX
No analyst data
ORCC
Analyst Ratings
9
Buy
4
Hold
1
Sell
Consensus: Buy
Price Target
$16.00
+18.7% upside vs current
Range: $16.00 — $16.00
Altman Z
0.5
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HRVIX buys
0
ORCC buys
0
No recent congressional trades found for HRVIX or ORCC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHRVIXORCC
Forward yield0.59%9.79%
Annual dividend / share$0.22$1.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%-50%
Portfolio after 10y$20.5K$21.4K
Annual income after 10y$61.47$1.04
Total dividends collected$604.00$1.0K
Payment frequencyquarterlyquarterly
SectorStockBDC

Year-by-year: HRVIX vs ORCC ($10,000, DRIP)

YearHRVIX PortfolioHRVIX Income/yrORCC PortfolioORCC Income/yrGap
1← crossover$10,759$59.16$11,190$489.61$431.00ORCC
2$11,572$59.48$12,229$256.01$657.00ORCC
3$12,442$59.79$13,216$130.74$774.00ORCC
4$13,373$60.08$14,207$66.02$834.00ORCC
5$14,369$60.35$15,234$33.17$865.00ORCC
6$15,435$60.60$16,317$16.62$882.00ORCC
7$16,577$60.84$17,468$8.32$891.00ORCC
8$17,798$61.07$18,695$4.16$897.00ORCC
9$19,105$61.28$20,006$2.08$901.00ORCC
10$20,504$61.47$21,407$1.04$903.00ORCC

HRVIX vs ORCC: Complete Analysis 2026

HRVIXStock

The fund invests primarily in a concentrated number (generally 40 to 70) of small-capitalization common stocks selected on a value basis. A majority of its assets are generally invested in dividend-paying common stocks. It primarily invests in companies with market capitalizations consistent with the capitalization range of the Russell 2000® Value Index.

Full HRVIX Calculator →

ORCCBDC

Owl Rock Capital Corporation is a business development company. The fund makes investments in senior secured or unsecured loans, subordinated loans or mezzanine loans and also considers equity-related securities including warrants and preferred stocks also pursues preferred equity investments and common equity investments. Within private equity, it seeks to invest in growth, acquisitions, market or product expansion, refinancings and recapitalizations. It seeks to invest in middle market companies based in the United States, with EBITDA between $10 million and $250 million annually and/or annual revenue of $50 million and $2.5 billion at the time of investment.

Full ORCC Calculator →
📬

Get this HRVIX vs ORCC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HRVIX vs SCHDHRVIX vs JEPIHRVIX vs OHRVIX vs KOHRVIX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.